Evidence map›Paper›PMID 32661005›Full record

ArticleAntimicrobial agents and chemotherapy2020

Antiretroviral Penetration and Drug Transporter Concentrations in the Spleens of Three Preclinical Animal Models and Humans.

Aaron S Devanathan, John K Fallon, Nicole R White, Amanda P Schauer, Brian Van Horne, Kimberly Blake, Craig Sykes, Martina Kovarova, Lourdes Adamson, Leila Remling-Mulder and 6 more

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. A Holistic Review of the Preclinical Landscape for Long-Acting Anti-infective Drugs Using HIV as a Paradigm.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Review
  7. Article
  8. Article
  9. Pharmacology of HIV Cure: Site of Action.Clinical pharmacology and therapeutics · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Aaron S DevanathanUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.ORCID 0000-0002-2778-3725
John K FallonUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.ORCID 0000-0003-1848-0121
Nicole R WhiteUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
Amanda P SchauerUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
Brian Van HorneUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
Kimberly BlakeUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
Craig SykesUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
Martina KovarovaUniversity of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Lourdes AdamsonUniversity of California, Davis, Davis, California, USA.
Leila Remling-MulderColorado State University, Fort Collins, Colorado, USA.
Paul LuciwUniversity of California, Davis, Davis, California, USA.
J Victor GarciaUniversity of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Ramesh AkkinaColorado State University, Fort Collins, Colorado, USA.
Jason R PironeUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
Philip C SmithUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
Angela D M KashubaUniversity of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA akashuba@unc.edu.
University of North Carolina at Chapel Hill · USColorado State University · USUniversity of California, Davis · US

Funding

National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
The Manhattan HIV Brain BankU24MH100931 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MORGELLO, SUSAN · 2013 to 2023
$14.0M
California NeuroAIDS Tissue NetworkU24MH100928 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ACHIM, CRISTIAN L, MOORE, DAVID J · 2013 to 2023
$13.9M
NATIONAL NEUROLOGICAL AIDS BANKU24MH100929 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SINGER, ELYSE J · 2013 to 2023
$12.5M
Texas NeuroAIDS Research CenterU24MH100930 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GELMAN, BENJAMIN B. · 2013 to 2023
$12.1M
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program-Evaluation SupplementT32GM086330 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KIM L.R. BROUWER, Daniel Gonzalez · 2011 to 2026
$8.5M
Multi-Species Mechanisms of Drug Bio-distribution in HIV Tissue ReservoirsR01AI111891 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KASHUBA, ANGELA D · 2014 to 2018
$4.3M
Shared UPLC-MS/MS for Absolute Quantitative ProteomicsS10RR024595 · NCRR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SMITH, PHILIP C · 2008 to 2008
$381k
NCRR NIH HHS S10 RR024595NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI064518NIAID NIH HHS R01 AI111891NIGMS NIH HHS T32 GM086330NIH HHS P51 OD011107NIMH NIH HHS U24 MH100928NIMH NIH HHS U24 MH100929NIMH NIH HHS U24 MH100930NIMH NIH HHS U24 MH100931
6 · The paper itself

Abstract

Adequate antiretroviral (ARV) concentrations in lymphoid tissues are critical for optimal antiretroviral therapy (ART). While the spleen contains 25% of the body's lymphocytes, there are minimal data on ARV penetration in this organ. This study quantified total and protein-unbound splenic ARV concentrations and determined whether drug transporters, sex, or infection status were modifiers of these concentrations in animal models and humans. Two humanized mice models (hu-HSC-Rag [

Indexed as

Anti-HIV AgentsHIV InfectionsPharmaceutical PreparationsAnimalsATP Binding Cassette Transporter, Subfamily G, Member 2Chromatography, LiquidHumansMacaca mulattaMiceModels, AnimalNeoplasm ProteinsSpleenTandem Mass SpectrometryAnti-HIV AgentsATP Binding Cassette Transporter, Subfamily G, Member 2Neoplasm ProteinsPharmaceutical Preparationsantiretroviralsdrug transporterspharmacokineticssex differencesspleen

Identifiers

PMID32661005
PMCPMC7508597
OpenAlexW3043428624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.